A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)
Clinical trial NCT04573023 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04573023
- Sponsor
- JCR Pharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-14
- Primary completion
- 2027-10-31
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.